On 4 January 2017 IMI (Innovative Medicines Initiative) launched its 10th call for submission of project proposals under the IMI 2 programme.
Deadline for submitting proposals under Call 10 is 28 March 2017.
University Children's Hospital (Universitäts-Kinderspital beider Basel, UKBB), Basel, Switzerland will hold the 3rd annual event for interdisciplinary challenges, preceded by a master class on commercial drug development in the morning of February 1, and a master class on Pediatric Drug development in the afternoon of February 1.
Registration is possible from now on >>>. A first draft agenda and further updates will be sent out in the next weeks and months.
Johannes van den Anker and Klaus Rose, as well as the organizing institutions, are looking forward to welcoming you at DMPRD at the Kinderspital beider Basel.
PELICAN Paediatric End-of-Life Care Needs in Switzerland:
In dieser Tagung werden die Ergebnisse der PELICAN-Studie vorgestellt und Empfehlungen für eine adäquate Gesundheitsversorgung im Bereich der Pädiatrischen Palliative Care diskutiert.
Hier geht es zum Flyer >>>
Nähere Informationen finden Sie hier >>>
The 5th radiz Rare Diseases Summer School will take place in the Tagungszentrum Schloss Au, Wädenswil (on lake Zurich), from June 7th to June 9th 2017.
A wide variety of subjects in the arena of rare diseases will be covered. There will be lectures by national and international rare disease experts, workshops, and poster presentations by participants. Subjects include drug development, model organisms, how to choose clinical endpoints, clinical trials, regulatory aspects, patient registries, patient initiated research, ethical considerations, as well as what rare diseases may tell us about common diseases.
radiz Summer School Flyer >>>
radiz Summer School Program >>>
Please refer to the website for current information.
The application deadline is February 27, 2017.
The European Commission (EC) has launched a public consultation to get views and feedback from stakeholders, to support the Commission in drafting its second report on the Paediatric Regulation after nearly ten years of implementation.
The consultation is open until 20 February 2017. Stakeholders should send their comments directly to the EC by accessing the consultation page >>>.
Conducting clinical trials in children requires specific competences and infrastructure. ECRIN-ERIC (www.ecrin.org) is a generic infrastructure for multinational trial management, in any disease area.
ECRIN receives now H2020 funding for the pediatric network 'PedCRIN', an upgrade of ECRIN to develop a common infrastructure for pediatric trial management through cooperation with the European Paediatric Clinical Trial Research Infrastructure (EPCTRI).
The SCTO resp. SwissPedNet is the Swiss partner of PedCRIN.
See also here >>>
The Nuffield Council, in collaboration with the Global Health Network, has produced a new online training course. The course is available in English and Spanish.
Available in English and Spanish, the course is aimed at researchers and members of ethics committees globally, to give them confidence in thinking through the challenges of carrying out research with children and young people. The course is free and open to anyone (though registration on the site is required), and takes 45-60 minutes to complete. A certificate is issued on successful completion.
This resource is based on the Council’s recent report which explores ethical issues around the involvement of children and young people in clinical research. It also draws on previous Council work on the ethics of healthcare research in developing countries.